"/> Tocris Bioscience™ CST 905 | B-LABO France

Tocris Bioscience™ CST 905

Réf. : BL-RE-158132Réf. fabricant : 18056062 5 mg
343,07 € HT

Potent and selective BRAFV600E Degrader (PROTAC™)

Nom chimique ou matériau
(2S,4R)-1-((S)-2-(2-(4-(4-(3-(3-((N-Ethyl-N-methylsulfamoyl)amino)-2,6-difluorobenzoyl)-1H-pyrrolo[2,3-b]pyridin-5-yl)phenyl)piperazin-1-yl)acetamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide
Quantité
5 mg
Cible
Active Degraders
Formule moléculaire
C51H58F2N10O7S2
Pureté
98%
Marque
Tocris Bioscience

CST 905 is a potent and selective BRAFV600E Degrader (PROTAC™) (DC50 = 18 nM). CST 905 comprises a ligand for the von Hippel Lindau (VHL) E3 ligase joined by a linker to a PLX-derived ligand. Unlike other BRAFV600E Degraders, CST 905 does not activate ERK. B-Raf antibody validated for Simple Western™ (automated Western) instruments and Western Blot also available: Catalog # AF3424 .

PROTAC™ is a registered trademark of Arvinas Operations, Inc., and is used under license.

Caractéristiques techniques

MarqueTocris Bioscience
Réf. B-LABOBL-RE-158132
Réf. fabricant18056062
Nom chimique ou matériau(2S,4R)-1-((S)-2-(2-(4-(4-(3-(3-((N-Ethyl-N-methylsulfamoyl)amino)-2,6-difluorobenzoyl)-1H-pyrrolo[2,3-b]pyridin-5-yl)phenyl)piperazin-1-yl)acetamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide
Quantité5 mg
CibleActive Degraders
Formule moléculaireC<sub>51</sub>H<sub>58</sub>F<sub>2</sub>N<sub>10</sub>O<sub>7</sub>S<sub>2</sub>
Pureté98%
Une question, une configuration particulière ?
Contactez-nous pour un devis.